Related Experiment Video
Updated: Oct 11, 2025
Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm
Bendix Labeit1,2, Thalia Grond1, Achim G Beule3
1Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.
Idiopathic inflammatory myopathy (IIM) can cause unexplained dysphagia. A new diagnostic algorithm successfully identified IIM in 19 patients, enabling targeted therapy and improved swallowing function.
Area of Science:
- Neurology
- Rheumatology
- Gastroenterology
Background:
- Idiopathic inflammatory myopathy (IIM) can manifest primarily as dysphagia.
- Diagnosing IIM is challenging when other symptoms and tests are inconclusive.
Purpose of the Study:
- To evaluate a diagnostic algorithm for identifying IIM in patients with unexplained dysphagia.
- To assess the efficacy of the algorithm in diagnosing and guiding treatment for IIM-induced dysphagia.
Main Methods:
- An observational study involving patients with unexplained dysphagia.
- Instrumental swallowing assessments (endoscopy, videofluoroscopy, manometry) were used.
- IIM-specific diagnostics included MRI, EMG, blood tests, antibody panels, and muscle biopsy.
Main Results:
- The algorithm identified 19 out of 72 patients with IIM presenting with dysphagia.
- Eighteen patients received immunomodulatory therapy.
- Dysphagia improved or stabilized in 9 out of 10 patients post-therapy.
Conclusions:
- IIM is a treatable cause of unexplained dysphagia.
- The proposed algorithm aids in identifying IIM and initiating appropriate management.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...